Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Imamura

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Carcinogenesis|December 12, 2017
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinomaTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.
Anticancer Research|August 28, 2025
Prevalence and Clinical Impact of Severe Periodontitis in Patients With Gastric CancerKazuya Takabatake, Takeshi Kubota, Hiroyuki Inoue, et al.
Oncotarget|August 28, 2016
Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinomaShuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, et al.
Expert Opinion on Biological Therapy|March 31, 2015
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasmaShuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Optimal Lymph Node Dissection and Prognosis for Primary Small Bowel Adenocarcinoma]Kaho Owada, Jun Kiuchi, Tomohiro Arita, et al.
Scientific Reports|February 24, 2025
Re-examining the optimal extent of lymph node dissection for colon cancer using the lymphadenectomy indexYuta Marunaka, Jun Kiuchi, Yoshiaki Kuriu, et al.
Oncotarget|October 18, 2019
Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junctionKenichi Aratani, Shuhei Komatsu, Daisuke Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy]Taisuke Imamura, Hisashi Ikoma, Ryo Morimura, et al.
British Journal of Cancer|October 28, 2015
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancerMahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, et al.
Asian Journal of Endoscopic Surgery|May 4, 2026
Tri-Scenario-Based MAICOHAN Strategy for Minimally Invasive Extended Left HepatectomyYusuke Yamamoto, Ryo Morimura, Taisuke Imamura, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Carcinogenesis|December 12, 2017
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinomaTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.
Anticancer Research|August 28, 2025
Prevalence and Clinical Impact of Severe Periodontitis in Patients With Gastric CancerKazuya Takabatake, Takeshi Kubota, Hiroyuki Inoue, et al.
Oncotarget|August 28, 2016
Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinomaShuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, et al.
Expert Opinion on Biological Therapy|March 31, 2015
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasmaShuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Optimal Lymph Node Dissection and Prognosis for Primary Small Bowel Adenocarcinoma]Kaho Owada, Jun Kiuchi, Tomohiro Arita, et al.
Scientific Reports|February 24, 2025
Re-examining the optimal extent of lymph node dissection for colon cancer using the lymphadenectomy indexYuta Marunaka, Jun Kiuchi, Yoshiaki Kuriu, et al.
Oncotarget|October 18, 2019
Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junctionKenichi Aratani, Shuhei Komatsu, Daisuke Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy]Taisuke Imamura, Hisashi Ikoma, Ryo Morimura, et al.
British Journal of Cancer|October 28, 2015
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancerMahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, et al.
Asian Journal of Endoscopic Surgery|May 4, 2026
Tri-Scenario-Based MAICOHAN Strategy for Minimally Invasive Extended Left HepatectomyYusuke Yamamoto, Ryo Morimura, Taisuke Imamura, et al.
Pageof 9